26 July 2018
Strong performance reflects consistent and rigorous execution of our strategy
…
SUMMARY OF UNAUDITED RESULTS …
July 26, 2018
Royal Dutch Shell plc (the ‘company’) today announces the immediate start of a share buyback programme in accordance with authority granted by shareholders at the company’s 2018 Annual General Meeting….
HIGHLIGHTS Record revenue of £611.5m, with growth at constant exchange rates of 18% Revenue growth in all metrology product lines. Revenue growth in all healthcare product lines. Record adjusted profit before tax of £145.1m, with growth of 33% Healthcare business achieves profit for the first time, with adjusted profit before tax of £0.3m (2017: £7.2m loss) Capital expenditure of £34.9m, providing for future growth Strong balance sheet, with cash of £103.8m, compared with £51.9m last year Dividend increased by 15% to 60.0p…
25 July 2018
GSK delivers improvements in sales (at CER), margins and cash flow in Q2 2018
Total EPS 9.0p, >100% AER, >100% CER; Adjusted EPS 28.1p, +3% AER, +10% CER
GSK sets out new approach to Research and Development and upgrades 2018 EPS guidance…
Group total revenue of €10.9 billion down 4.9% reflecting the adoption of IFRS 15 and FX headwinds Q1 organic service revenue grew 1.1%* based on IFRS 15 Europe declined by 1.3% but grew 0.5%* excluding drags from regulation and UK handset financing.
Marston's PLC “the Group” issues the following Trading Update for the 42 weeks to 21 July 2018. …
Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the third quarter (Q3) covering the period 1 April to 30 June 2018….